<DOC>
	<DOCNO>NCT01407497</DOCNO>
	<brief_summary>While antiretroviral drug show great promise reduce HIV replication thus reduce HIV/AIDS associate morbi-mortality HIV transmission , cost substantial side effect potentially limit factor . Development effective safe-affordable vaccine likely best way stop virus spread . The study aim determine safety immunogenicity DNA-vaccine dose 600µg 1200µg deliver id combination MVA-CMDR boost im .</brief_summary>
	<brief_title>Safety Immunogenicity Study DNA Priming MVA Boosting Strategy HIV Vaccine</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>1 . Age : 18 26 year 2 . Willing undergo HIV ( Human Immunodeficiency Virus ) counsel test 3 . Have negative antigen/antibody antibody ELISA HIV infection 4 . Able give inform consent 5 . Satisfactory completion assessment understand prior enrolment define 89 % correct answer three opportunity take test 6 . Basic ability read write 7 . Resident Maputo , willing remain duration study 8 . At low risk HIV infection , define absence identifiable risk factor/ behavior ( presence therefore exclusion criterion ) : sexual partner HIV sexual partner unknown HIV serostatus also unwilling use protective condom consistently sexual relation sexual partner know high risk HIV one sexual partner last 6 month history alcoholic [ medically define 35 unit /week ] history Sexually Transmitted Infection ( STI ) within past 6 month 9 . Verbal assurance adequate birth control method use conceive/father child study 3 month last vaccine injection . 10 . Women shall negative urine pregnancy test 11 . Be willing practice safe sex duration study avoid sexually transmitted infection include HIV 12 . Good health determine medical history , physical examination , clinical judgment key laboratory parameter judge study physician . 13 . Laboratory criterion : Hemoglobin &gt; 10.5g/dl White blood cell count &lt; 13,000/mm3 Neutrophils &gt; 1,300/mm3 Lymphocytes &gt; 1.000/ mm3 Platelets &gt; 120,000/ mm3 Random Blood Glucose &lt; 6.44 mmol/L ; elevate , Fasting Blood Glucose &lt; 6.11mmol/L ( accord DAIDS Table Lab Criteria ) Bilirubin &lt; 1.25 x uln Alanine transaminase ( ALT ) &lt; 1.25 x uln Urine dipstick protein blood : negative trace . ( If either ¿ 1+ , complete urinalysis ( UA ) perform . 1 . At risk HIV infection mention inclusion criterion 2 . Active tuberculosis systemic infectious process elicit review system , physical examination laboratory detection 3 . A history immunodeficiency , chronic illness require continuous frequent medical intervention 4 . Autoimmune disease history physical examination 5 . Hives recurrent hive severe eczema 6 . A history psychiatric , medical ( include traditional medicine ) and/or substance abuse problem past 6 month investigator believe would adversely affect volunteer 's ability participate trial 7 . History epilepsy , currently take antiepileptic 8 . Received blood blood product immunoglobulins past 3 month 9 . Receiving immunosuppressive therapy systemic corticosteroid cancer chemotherapy 10 . Use experimental therapeutic agent within 30 day study entry 11 . Reception live , attenuated vaccine within 60 day study entry . 12 . Abnormality Electrocardiogram ( ECG ) could indicate risk make interpretation vaccine effect difficult accord study operating procedures 13 . Previously receive HIV vaccine candidate 14 . History severe local general reaction vaccination define : Local : Extensive , indurate redness swell involve major circumference arm , resolve within 72 hour General : Fever &gt; = 39.5 0C within 48 hour ; anaphylaxis ; bronchospasm ; laryngeal edema ; collapse ; convulsion encephalopathy within 72 hour 15 . Being lactate mother 16 . Study site employee involve protocol may direct access immunogenicity result 17 . Unlikely comply protocol judge principal investigator designate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>HIV</keyword>
	<keyword>Vaccine</keyword>
	<keyword>DNA</keyword>
	<keyword>Prevention</keyword>
</DOC>